-
A leap forward for hypersonic flight
23 Apr 2024 21:08 GMT
… the next generation of wireless spectrum communications.
POLITICO’s Mathieu Pollet and …
-
Lake Alfred city commissioner charged with 300 counts of child porn possession
19 Apr 2024 15:46 GMT
… account that belonged to a Spectrum Communications customer in the Lake Alfred …
-
Governor Cooper Calls on Walt Disney Company and Charter Spectrum Communications to Reach Broadcast Agreement So North Carolinians Can Cheer on Favorite Teams This Fall
07 Sep 2023 03:43 GMT
… Walt Disney Company and Charter Spectrum Communications urging them to end their … ruined because of the Charter Spectrum Communications and Disney dispute. Not only …
-
MaxCyte to Report First Quarter 2024 Financial Results on May 7, 2024
10 Apr 2024 12:05 GMT
…
+1 408-497-8568
venes@spectrumscience.com Nominated Adviser and Joint Corporate …
-
NewAmsterdam Pharma Enrolls Over 9,000 Patients in Pivotal Phase 3 PREVAIL Global Cardiovascular Outcome Trial Evaluating the Effect of Obicetrapib in Patients with Established Atherosclerotic Cardiovascular Disease
09 Apr 2024 12:00 GMT
… : 1-202-957-7795
jgordon@spectrumscience.com Investor Contact
Stern Investor Relations …
-
MaxCyte Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell Medicines (BCMs)
02 Apr 2024 12:05 GMT
… Seismic Collaborative
Anya Bolshem
abolshem@spectrumscience.com
+1 732-284-1751 Nominated …
-
NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer
01 Apr 2024 12:00 GMT
… : 1-202-957-7795
jgordon@spectrumscience.com Investor Contact
Stern Investor Relations …
-
Food Pantry accepts check from Charter Spectrum Communications
27 Jan 2021 21:39 GMT
… on Jan. 22 from Charter Spectrum Communications. The Pantry is grateful for …
-
NewAmsterdam Pharma to Present New Analysis from the Phase 2 ROSE2 Trial Evaluating Obicetrapib in Combination with Ezetimibe at 2024 American College of Cardiology Congress
25 Mar 2024 12:00 GMT
… : 1 202-957-7795
jgordon@spectrumscience.com Investor Contact
Stern Investor Relations …
-
MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
12 Mar 2024 20:05 GMT
…
+1 408-497-8568
venes@spectrumscience.com Nominated Adviser and Joint Corporate …